U.S. markets open in 1 hour 35 minutes

Allscripts Healthcare Solutions, Inc. (MDRX)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
17.48+0.01 (+0.06%)
At close: 04:00PM EDT
17.55 +0.07 (+0.40%)
After hours: 04:37PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Commodity Channel Index

Commodity Channel Index

Previous Close17.47
Bid0.01 x 1400
Ask19.28 x 800
Day's Range17.23 - 17.69
52 Week Range13.05 - 23.25
Avg. Volume1,564,756
Market Cap1.937B
Beta (5Y Monthly)1.02
PE Ratio (TTM)18.80
EPS (TTM)0.93
Earnings DateNov 02, 2022 - Nov 07, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateOct 07, 2008
1y Target Est21.60
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
-17% Est. Return

Subscribe to Yahoo Finance Plus to view Fair Value for MDRX

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Allscripts Healthcare Solutions
    Analyst Report: Allscripts Healthcare Solus InAllscripts Healthcare Solutions Inc. is a leading provider of electronic health record solutions for physicians, group practices, ambulatory facilities, and hospitals. Allscripts is also a provider of practice management systems, clinical software, and connectivity solutions for physicians. The company's products streamline diagnosis, treatment, and claims processing by allowing physicians to efficiently manage patient information. The company has 9,600 employees. The shares are a component of the S&P 600 Small-Cap Index.
    Fair Value
    Economic Moat
    2 days agoArgus Research
View more